Sartorius Stedim Biotech S.A.
SDMHF
$193.02
-$26.41-12.04%
OTC PK
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 12.24% | 11.21% | 5.25% | -0.74% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 12.24% | 11.21% | 5.25% | -0.74% | |
| Cost of Revenue | 14.30% | 5.50% | -4.94% | -1.94% | |
| Gross Profit | 9.41% | 18.66% | 23.45% | 0.97% | |
| SG&A Expenses | 6.72% | 11.24% | 1.09% | 4.36% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -213.16% | 108.38% | 91.70% | 55.50% | |
| Total Operating Expenses | 8.90% | 7.90% | 9.22% | 2.14% | |
| Operating Income | 31.66% | 30.29% | -13.11% | -19.49% | |
| Income Before Tax | 107.46% | 49.14% | -31.13% | -24.19% | |
| Income Tax Expenses | 716.81% | 50.63% | -131.45% | -24.45% | |
| Earnings from Continuing Operations | 11.33% | 48.62% | 9.67% | -24.10% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 115.60% | -- | 50.49% | -34.67% | |
| Net Income | 13.28% | 51.74% | 11.76% | -25.13% | |
| EBIT | 31.66% | 30.29% | -13.11% | -19.49% | |
| EBITDA | 23.72% | 21.95% | -12.67% | -9.96% | |
| EPS Basic | 13.69% | 45.50% | 6.13% | -29.03% | |
| Normalized Basic EPS | 36.92% | 46.61% | 2,588.00% | -- | |
| EPS Diluted | 13.69% | 45.50% | 6.13% | -29.03% | |
| Normalized Diluted EPS | 36.92% | 46.61% | 2,588.00% | -- | |
| Average Basic Shares Outstanding | -0.37% | 4.28% | 5.30% | 5.49% | |
| Average Diluted Shares Outstanding | -0.37% | 4.28% | 5.30% | 5.49% | |
| Dividend Per Share | 9.20% | -- | -0.98% | -- | |
| Payout Ratio | -- | -0.31% | -- | -- | |